Medical device developer Medtronic said it has completed patient enrollment for the Vascular Talent Thoracic Stent Graft System for the Treatment of Thoracic Aortic Aneurysms (VALOR), a clinical trial to evaluate the safety and efficacy of its Talent thoracic stent graft system for the treatment of thoracic aortic diseases.
The prospective nonrandomized multicenter study has three arms and 359 patients at 40 clinical centers in the U.S., according to the Minneapolis-based firm.
The study will evaluate the Talent thoracic stent-graft system across three patient groups, including candidates for open surgical repair, those with type B thoracic aortic dissections, and those who are considered high-risk, nonsurgical candidates, Medtronic said.
By AuntMinnie.com staff writers
June 17, 2005
Related Reading
Medtronic gets nod for multipurpose catheter, June 8, 2005
Medtronic begins Endeavor IV trial, April 13, 2005
New identity for Medtronic surgical navigation unit, April 7, 2005
Medtronic loses verdict in Cordis trial, March 15, 2005
Stent wars heat up, Medtronic on target, March 8, 2005
Copyright © 2005 AuntMinnie.com
